THL Partners

We’re pleased to share that our Head of Technology and Business Solutions Jim Carlisle has been named on GrowthCap’s Top 25 Software Investors of 2024 list. This year’s competitive list features investors from across the industry who demonstrate high level investment performance, specialized knowledge in software, and consistently produce positive outcomes. Congratulations to Jim on this great achievement and for his leadership at THL Partners. Please see additional information here. https://lnkd.in/erEgQ96A ??

The convergence of AI and pharmaceutical development is transforming the way we treat rare diseases. Historically, creating treatments for these conditions was challenging due to small patient populations, high R&D costs, and uncertain ROI. But AI is changing the game. By connecting learnings from seemingly unrelated areas of research, we can now accelerate the identification of new disease targets, develop specialized drugs, and even optimize manufacturing processes. New technology may hold the potential to “speed up the cycle of bringing these drugs through the clinical pipeline,” says Peter McClelland, Principal at THL Partners.

Michael Manos, CTO of our portfolio company Dun & Bradstreet, shares key insights with the Forbes Technology Council on Gen AI implementation - read more below.

The healthcare ecosystem can be complicated and dynamic. Although the analyses have gotten more sophisticated, Jon Lange, Director at THL Partners, notes that in many ways “we’re still focused on a lot of the same issues” as when he took his first summer job in healthcare 20 years ago.?“We’re still seeing progress in value-based care and we still think it’s the future”.? ? At THL we’re focused on a range of healthcare sectors where patient service models are changing, technology is driving better outcomes and data analysis is addressing long-standing impediments to improving patient outcomes. ? To learn more about our work in the industry and Jon’s journey from teen to PE Healthcare investor, follow the link below: ? #healthcare #innovation #investing

THL Partners congratulates AutoStore? on the launch of its new Grid capabilities, including the Multi-Temperature Solution and 18-Level Grid expansion. Available for order Q1 2025, these innovations directly enhance storage density, safety, and operational efficiency.

This week, THL Partners announced a majority investment in?AMI. Head of Technology & Business Solutions Jim Carlisle spoke with Reuters’s Milana Vinn about how THL plans to leverage the company's deep experience in semiconductors and software to address the artificial intelligence boom. Access the full story here: https://lnkd.in/ezs3GtJ3

THL Partners is excited to announce a majority investment in?AMI, a global leader in Dynamic Firmware for computing platforms. AMI provides leading technology companies with silicon level software required to power and boot, manage, orchestrate, and secure modern computing environments. Over 60% of servers that power data centers and the cloud rely on AMI firmware, uniquely positioning the company to support the substantial and growing need for firmware driven by the growth of artificial Intelligence (AI) and hyperscale cloud infrastructure.? THL invests in fast-growing sectors?— such as Infrastructure Software and Security. With?AMI, we saw an opportunity to partner with an industry leader. https://lnkd.in/ezs3GtJ3

AI has the potential to revolutionize healthcare, beginning with operational improvements that simplify provider workflows. While clinical applications of AI are advancing cautiously, the current innovations are already helping to ease the burden on providers and enhance patient care. Shahab Vagefi, MD at THL Partners, highlights how our portfolio company, IMO Health, is leveraging AI alongside their existing tools to elevate data quality in healthcare.?Listen here for more:

AI has the potential to revolutionize healthcare, beginning with operational improvements that simplify provider workflows. While clinical applications of AI are advancing cautiously, the current innovations are already helping to ease the burden on providers and enhance patient care. Shahab Vagefi, MD at THL Partners, highlights how our portfolio company, IMO Health, is leveraging AI alongside their existing tools to elevate data quality in healthcare.?Listen here for more:?

THL Partners is focused on investments that enhance the quality of patient care and experience, while also improving healthcare system efficiency. Join Todd Abbrecht, co-CEO, while he discusses how our approach involves deep industry expertise and a commitment to understanding the mission behind each healthcare investment. By specializing in high-growth sectors, we ensure our teams are dedicated to driving success and impact where it matters most. ?